Qvanteq
About:
Qvanteq is a medtech startup company, developing surface technology that can be applied onto any coronary stent.
Website: http://www.qvanteq.com
Top Investors: Verve Ventures, Venture Kick
Description:
Qvanteq is a medtech startup company, developing novel bioactive stents to address and overcome the clinical adverse effects of today’s available coronary and endovascular stents. Its bioactive Qstent controls in-growth therefore reducing the risk of restenosis and thrombosis. The company was awarded with the CTI start-up label in 2012. Qvanteq was founded in 2009 and is held by private investors. The ISO 13485 certified company is based in Zürich, Switzerland. It is a spin-off company from the Swiss Federal Institute of Technology, Zurich.
4.01M CHF
Zürich, Zurich, Switzerland
2009-01-01
info(AT)qvanteq.com
Arik Zucker
1-10
2013-02-12
Private
© 2025 bioDAO.ai